Manifold Bio
Tissue-targeted medicines, designed in vivo
About Manifold Bio
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Pitch deck breakdown
How Manifold Bio would pitch themselves.
Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
Problem they solve
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered de… The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Manifold Bio differentiates on tissue-targeted medicines, designed in vivo. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Series-A scaling stage — building outbound sales motion, hiring first AEs, layering on customer success. Mix of PLG (where the product allows) + direct sales for higher-ACV deals.
Manifold Bio website preview
Company facts
- Category
- SaaS
- Funding stage
- Series A
- Total raised
- $0
- Founded
- 2020
- Team size
- 11–50
- HQ
- Boston, United States
- Country
- United States
- Website
- manifold.bio
Frequently asked questions
What does Manifold Bio do?
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Where is Manifold Bio based?
Manifold Bio is based in Boston, United States, United States.
When was Manifold Bio founded?
Manifold Bio was founded in 2020.
How much has Manifold Bio raised?
Manifold Bio has raised $0 in their Series A round.